MyEClinic
MyEClinic
Health Dictionary Find a Doctor

CTD regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Overview

Overview

CTD regimen refers to a regimen consisting of Cyclophosphamide, Thalidomide, Dexamethasone used to treat Multiple myeloma unsuitable for autologous transplantation[1]

Regimen

Regimen

CCyclophosphamide

TThalidomide

DDexamethasone

Indications

Indications

References

References

  1. ↑ 1.0 1.1 Morgan GJ, Davies FE, Gregory WM, Russell NH, Bell SE, Szubert AJ; et al. (2011). “Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation”. Blood. 118 (5): 1231–8. doi:10.1182/blood-2011-02-338665. PMC 3152492. PMID 21652683.

Looking for the patient version?

Back to the patient-friendly article

Imprint

Privacy Policy

Terms and Conditions

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH